10, 2018. China's drug authority on Wednesday approved inclusion of 17 anti-cancer drugs in the government's basic medical insurance programs. (Xinhua/Huang Zongzhi) 1 2 Next KEY WORDS:anti-cancer drugs YOU MAY LIKE Chinese vice premier calls for better medical insurance service China ...
Anti-Cancer Drugs is devoted to the rapid publication of innovative investigations on therapeutic agents against cancer and methods to diminish adverse effects of drugs. The journal publishes peer reviewed articles on anti-cancer drug design, drug delivery, pharmacology and chemotherapy evaluation. SUBMISS...
Posted inCANCER BIOLOGY & Innovations in Cancer Therapy,Cancer Prevention: Research & Programs,Clinical & Translational,Disease Biology, Small Molecules in Development of Therapeutic Drugs,FDA Regulatory Affairs,Health Economics and Outcomes Research,Pharmaceutical Discovery,Pharmaceutical Drug Discovery,Pharmaceut...
No significant effect on cancer risk has been reported with orlistat. Orlistat interferes with the absorption of many drugs (such as warfarin, amiodarone, ... Filippatos,Theodosios,D.,... - 《Drug Safety》 被引量: 200发表: 2008年 SELF-NANOEMULSIFYING OILY FORMULATION FOR THE ADMINISTRATION ...
Therefore, inhibition of cancer-specific enhancer activity is a current direction in anti-cancer drug development15,16,17. Indeed, pharmacological inhibition of transcriptional activators that are involved in SE function leads to selective downregulation of oncogene expression and cancer cell death18,19,...
Frontiers in Anti-Cancer Drug Discovery is a book series devoted to publishing the latest advances in anti-cancer drug design and discovery. In each volume, eminent scientists contribute reviews relevant to all areas of rational drug design and drug discovery including medicinal chemistry, in-silico...
Therefore, we propose the CMax viability, a novel drug sensitivity measure based on the highest, clinically relevant drug dose as described in30. We define drug prioritization as the task of identifying and subsequently sorting the list of effective drugs. As such it is similar in spirit to ...
Within tumor-specific cohorts, "Maintain/improve quality of life" was a notable reason for drug therapy decisions in both breast and colorectal cancer patient subsets in 2023 (10% and 19% respectively). Contrary to the overall patient cohort, drug therapy choice for reported prostate cancer ...
Background: Despite the substantial contribution of natural products to the FDA drug approval list, the discovery of anti-cancer drugs from the huge amount of species on the planet remains looking for a needle in a haystack.Li, XiaofengLi, XiaoxuLi, YinghongYu, ChunyanXue, WeiweiHu, JieLi, ...
Frontiers in Clinical Drug Research - Anti-Cancer Agentsis an eBook series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are ...